ELTX
Elicio Therapeutics Inc.
NASDAQ: ELTX · HEALTHCARE · BIOTECHNOLOGY
$10.62
+2.91% today
Updated 2026-04-30
Market cap
$215.05M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.58
Dividend yield
—
52W range
$5 – $15
Volume
0.1M
Elicio Therapeutics Inc. (ELTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-60,013.00%
ROA
-87.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $7.30M | $307303.00 | 49.66% | -5.74% | 4.21% |
| 2013 | $6.58M | $632241.00 | 51.78% | -6.04% | 9.61% |
| 2018 | $4.03M | $-20.02M | 90.57% | -355.97% | -497.02% |
| 2019 | $1.49M | $-40.66M | 23.60% | -2,595.23% | -2,734.23% |
| 2020 | $2.88M | $-80.11M | 36.88% | -1,919.20% | -2,781.49% |
| 2021 | $28.31M | $-26.40M | 95.64% | -138.84% | -93.25% |
| 2022 | $0.00 | $-28.21M | — | — | — |
| 2023 | $0.00 | $-35.20M | — | — | — |
| 2024 | $0.00 | $-51.90M | — | — | — |
| 2025 | $0.00 | $-39.57M | — | — | — |